Journal of Clinical Pediatrics ›› 2022, Vol. 40 ›› Issue (5): 388-394.doi: 10.12372/jcp.2022.21e1384
• General Report • Previous Articles Next Articles
SONG Na, SUN Ming, QI Shanshan, WANG Zhuo, YANG Li, LU Wenjie, WU Min, XIA Wei, CHEN Yan, XIONG Hao(
)
Received:2021-09-29
Published:2022-05-15
Online:2022-05-13
Contact:
XIONG Hao
E-mail:22587481@qq.com
SONG Na, SUN Ming, QI Shanshan, WANG Zhuo, YANG Li, LU Wenjie, WU Min, XIA Wei, CHEN Yan, XIONG Hao. Clinical research on cellular immune reconstitution after allogeneic hematopoietic stem cell transplantation in children[J].Journal of Clinical Pediatrics, 2022, 40(5): 388-394.
"
| 时间 | 组别 | CD16+ CD56+ NK细胞 | CD3+ T细胞 | CD4+ T细胞 | |||
|---|---|---|---|---|---|---|---|
| M(P25~P75) | 统计分析 | M(P25~P75) | 统计分析 | M(P25~P75) | 统计分析 | ||
| 移植前 | non-aGVHD(n=26) | 56.0(27.5~121.3) | Z=0.00 | 925.0(436.0~1 687.5) | Z=0.09 | 406.5(197.3~1119.5) | Z=1.55 |
| aGVHD(n=16) | 60.0(19.8~181.8) | P=1.000 | 1 046.5(243.0~1 974.3) | P=0.928 | 230.0(108.3~726.5) | P=0.120 | |
| 0 d | non-aGVHD(n=26) | 0.0(0.0~0.0) | Z=0.31 | 1.0(0.0~8.0) | Z=1.93 | 0.0(0.0~6.0) | Z=2.11 |
| aGVHD(n=16) | 0.0(0.0~0.0) | P=0.758 | 10.0(1.0~17.0) | P=0.053 | 7.0(1.0~13.0) | P=0.035 | |
| 14 d | non-aGVHD(n=26) | 3.0(0.0~14.0) | Z=0.17 | 4.0(0.0~119.0) | Z=1.65 | 2.0(0.0~65.0) | Z=1.15 |
| aGVHD(n=16) | 2.5(0.3~13.3) | P=0.862 | 47.5(6.5~124.5) | P=0.099 | 16.5(1.5~34.5) | P=0.249 | |
| 21 d | non-aGVHD(n=26) | 46.5(7.5~154.0) | Z=1.10 | 130.0(20.3~285.3) | Z=1.17 | 42.0(13.3~73.5) | Z=1.30 |
| aGVHD(n=16) | 25.0(8.0~55.0) | P=0.273 | 275.0(40.0~565.0) | P=0.242 | 70.0(13.0~117.0) | P=0.194 | |
| 28 d | non-aGVHD(n=26) | 186.0(77.3~389.8) | Z=2.28 | 301.0(124.8~939.8) | Z=0.98 | 81.5(28.5~141.3) | Z=0.76 |
| aGVHD(n=16) | 53.0(22.0~170.0) | P=0.023 | 333.0(80.0~589.0) | P=0.326 | 54.0(21.5~151.0) | P=0.447 | |
| 60 d | non-aGVHD(n=26) | 314.0(143.5~883.0) | Z=2.61 | 1 074.0(338.0~2 319.0) | Z=1.69 | 171.0(100.0~303.5) | Z=1.88 |
| aGVHD(n=16) | 152.0(54.0~218.0) | P=0.009 | 450.5(190.3~1351.0) | P=0.092 | 107.0(67.3~129.5) | P=0.060 | |
| 100 d | non-aGVHD(n=26) | 366.0(246.0~1 024.0) | Z=1.90 | 1 239.0(804.0~2 406.0) | Z=1.58 | 206.0(148.5~357.5) | Z=2.19 |
| aGVHD(n=16) | 269.0(155.0~387.0) | P=0.057 | 562.0(240.0~1921.0) | P=0.114 | 106.0(59.0~240.0) | P=0.028 (个/µL) | |
"
| 时间 | 组别 | CD8+ T细胞 | CD19+ B细胞 | CD4+CD25+ Treg细胞 | |||
|---|---|---|---|---|---|---|---|
| M(P25~P75) | 统计分析 | M(P25~P75) | 统计分析 | M(P25~P75) | 统计分析 | ||
| 移植前 | non-aGVHD(n=26) | 502.5(213.3~712.8) | Z=0.18 | 48.5(1.0~150.0) | Z=0.83 | 67.0(38.8~121.5) | Z=0.84 |
| aGVHD(n=16) | 437.5(143.8~1 038.0) | P=0.856 | 22.5(1.0~86.8) | P=0.406 | 61.5(24.8~100) | P=0.400 | |
| 0 d | non-aGVHD(n=26) | 0.0(0.0~2.0) | Z=1.37 | 0.0(0.0~0.0) | Z=1.16 | 0.0(0.0~2.0) | Z=1.28 |
| aGVHD(n=16) | 1.0(0.0~3.0) | P=0.172 | 0.0(0.0~0.0) | P=0.247 | 1.0(0.0~6.0) | P=0.200 | |
| 14 d | non-aGVHD(n=26) | 1.0(0.0~40.0) | Z=1.89 | 0.0(0.0~1.0) | Z=0.93 | 0.0(0.0~4.0) | Z=0.08 |
| aGVHD(n=16) | 22.0(1.8~107.5) | P=0.059 | 0.0(0.0~0.0) | P=0.353 | 0.0(0.0~6.5) | P=0.938 | |
| 21 d | non-aGVHD(n=26) | 77.5(9.5~264.3) | Z=1.31 | 0.0(0.0~1.0) | Z=0.26 | 6.0(1.0~15.8) | Z=0.55 |
| aGVHD(n=16) | 119.0(27.0~474.0) | P=0.189 | 0.0(0.0~1.0) | P=0.799 | 2.0(1.0~14.0) | P=0.581 | |
| 28 d | non-aGVHD(n=26) | 216.0(63.3~676.5) | Z=0.86 | 0.0(0.0~3.0) | Z=1.46 | 10.0(2.8~26.5) | Z=1.26 |
| aGVHD(n=16) | 196.0(51.0~411.5) | P=0.388 | 0.0(0.0~0.5) | P=0.145 | 1.0(1.0~15.0) | P=0.209 | |
| 60 d | non-aGVHD(n=26) | 922.0(265.5~1 767.5) | Z=1.56 | 1.0(0.0~95.5) | Z=1.50 | 19.0(5.5~44.5) | Z=2.66 |
| aGVHD(n=16) | 320.5(112.8~1 273.5) | P=0.119 | 0.5(0.0~2.5) | P=0.134 | 2.0(0.3~17.0) | P=0.008 | |
| 100 d | non-aGVHD(n=26) | 957.0(674.5~2 120.0) | Z=1.66 | 37.0(0.0~95.5) | Z=1.82 | 29.0(18.0~46.5) | Z=1.36 |
| aGVHD(n=16) | 446.0(224.0~1 605.0) | P=0.096 | 2.0(0.0~25.0) | P=0.069 | 19.0(4.0~38.0) | P=0.175 | |
| [1] |
Elfeky R, Lazareva A, Qasim W, et al. Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources[J]. Expert Rev Clin Immunol, 2019, 15(7): 735-751.
doi: 10.1080/1744666X.2019.1612746 |
| [2] |
Kim HO, Oh HJ, Lee JW, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation in children: a single institution study of 59 patients[J]. Korean J Pediatr, 2013, 56(1): 26-31.
doi: 10.3345/kjp.2013.56.1.26 |
| [3] | 中华医学会血液学分会干细胞应用学组. 中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅰ)-适应证、预处理方案及供者选择(2014年版)[J]. 中华血液学杂志, 2014, 35(8): 775-780. |
| [4] | 中华医学会血液学分会干细胞应用学组. 中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)-急性移植物抗宿主病(2020年版)[J]. 中华血液学杂志, 2020, 41(7): 529-536. |
| [5] |
Pei XY, Zhao XY, Xu LP, et al. Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation[J]. Bone Marrow Transplant, 2017, 52(11): 1556-1562.
doi: 10.1038/bmt.2017.174 |
| [6] |
Park BG, Park CJ, Jang S, et al. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients[J]. Leuk Res, 2015, 39(12): 1334-1341.
doi: 10.1016/j.leukres.2015.09.010 |
| [7] |
de Koning C, Plantinga M, Besseling P, et al. Immune reconstitution after allogeneic hematopoietic cell transplantation in children[J]. Biol Blood Marrow Transplant, 2016, 22(2):195-206.
doi: 10.1016/j.bbmt.2015.08.028 |
| [8] | Ullah MA, Hill GR, Tey SK. Functional reconstitution of natural killer cells in allogeneic hematopoietic stem cell transplantation[J]. Front Immunol, 2016, 7: 144. |
| [9] |
Gao F, Ye Y, Gao Y, et al. Influence of KIR and NK cell reconstitution in the outcomes of hematopoietic stem cell transplantation[J]. Front Immunol, 2020, 11: 2022.
doi: 10.3389/fimmu.2020.02022 |
| [10] |
Huttunen P, Taskinen M, Siitonen S, et al. Impact of very early CD4+ /CD8+ T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation[J]. Pediatr Blood Cancer, 2015, 62(3): 522-528.
doi: 10.1002/pbc.25347 pmid: 25417898 |
| [11] |
Stern L, McGuire H, Avdic S, et al. Mass cytometry for the assessment of immune reconstitution after hematopoietic stem cell transplantation[J]. Front Immunol, 2018, 9: 1672.
doi: 10.3389/fimmu.2018.01672 |
| [12] |
Chaudhry MS, Velardi E, Malard F, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation: time to T up the thymus[J]. J Immunol, 2017, 198(1):40-46.
doi: 10.4049/jimmunol.1601100 |
| [13] | 霍莹莹, 庞爱明, 程涛达. 异基因造血干细胞移植后造血及免疫重建研究进展[J]. 中华血液学杂志, 2020, 41(11): 958-963. |
| [14] |
Ritacco C, Ehx G, Grégoire C, et al. High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2021, 56(8):1828-1841.
doi: 10.1038/s41409-021-01221-0 |
| [15] |
Bosch M, Khan FM, Storek J. Immune reconstitution after hematopoietic cell transplantation[J]. Curr Opin Hematol, 2012, 19(4): 324-335.
doi: 10.1097/MOH.0b013e328353bc7d pmid: 22517587 |
| [16] |
Giaccone L, Faraci DG, Butera S, et al. Biomarkers for acute and chronic graft versus host disease: state of the art[J]. Expert Rev Hematol, 2021, 14(1): 79-96.
doi: 10.1080/17474086.2021.1860001 pmid: 33297779 |
| [17] |
Bunting MD, Varelias A, Souza-Fonseca-Guimaraes F, et al. GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity[J]. Blood, 2017, 129(5): 630-642.
doi: 10.1182/blood-2016-08-734020 pmid: 27927647 |
| [18] |
Zhang X, Peng Y, Fan Z, et al. Mesenchymal stem cells may ameliorate nephrotic syndrome post-allogeneic hematopoietic stem cell transplantation-case report[J]. Front Immunol, 2017, 8: 962.
doi: 10.3389/fimmu.2017.00962 pmid: 28855905 |
| [19] | Shokouhi S, Bray S, Bakhtiyari S, et al. Effects of aGVHD and cGVHD on survival rate in patients with acute myeloid leukemia after allogeneic stem cell transplantation[J]. Int J Hematol Oncol Stem Cell Res, 2015, 9(3): 112-121. |
| [20] |
Sheng L, Mu Q, Wu X, et al. Cytotoxicity of donor natural killer cells to allo-reactive T cells are related with acute graft-vs.-host-disease following allogeneic stem cell transplantation[J]. Front Immunol, 2020, 11: 1534
doi: 10.3389/fimmu.2020.01534 |
| [1] | LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28. |
| [2] | LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34. |
| [3] | ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55. |
| [4] | JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13. |
| [5] | QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752. |
| [6] | FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773. |
| [7] | JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790. |
| [8] | ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review [J]. Journal of Clinical Pediatrics, 2024, 42(9): 798-804. |
| [9] | CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816. |
| [10] | DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672. |
| [11] | LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677. |
| [12] | HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683. |
| [13] | WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690. |
| [14] | MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703. |
| [15] | WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727. |
|
||